* 中国医药纳米材料解决方案提供商--剂泰科技7666.HK周三香港首日挂牌高开173%后，盘扩一度大涨幅至186%，触及29.98港元。
* 该公司此前以招股价每股10.5港元发售约2.01亿股H股，集资21.1亿港元，香港公开发售和国际配售分别获约6,910倍及33倍超额认购。
* 另一家同日挂牌、专注于抗癌疗法的中国生物技术公司--英派药业7630.HK高开77%后亦一度扩大升幅至82%，触及36.5港元。
* 该公司此前以招股价区间中低端定价，为每股20.1港元，香港H股上市筹约8.4亿港元，公开发售和国际配售分别获约2,281倍及24倍超额认购。（完）更多股市简讯请点选CN-CMN-HOT
(记者 雷美珍；审校 杨淑祯)
((alison.lui@thomsonreuters.com; +852 3462 7749))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.